ACL-508 - Chong Kun Dang, Archela
Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects (clinicaltrials.gov) - Aug 7, 2020 - P1 | N=72 | Recruiting | Sponsor: Chong Kun Dang Pharmaceutical 
First-in-human • New P1 trial
http://clinicaltrials.gov/ct2/show/NCT04488900
 
Aug 7, 2020
 
Prev